Details

Primerjava naložbenega zavarovanja Junior s konkurenčnimi zavarovanji v Sloveniji : diplomsko delo
ID Štefančič, Miha (Author), ID Hartman, Rasto (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://www.cek.ef.uni-lj.si/u_diplome/stefancic4623.pdf This link opens in a new window

Language:Slovenian
Keywords:Slovenija, zavarovalstvo, življenjsko zavarovanje, investicije, investicijski skladi, konkurenca, komparacije
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:EF - School of Economics and Business
Place of publishing:Ljubljana
Publisher:[M. Štefančič]
Year:2011
Number of pages:III, 42 str.
PID:20.500.12556/RUL-16183 This link opens in a new window
UDC:368
COBISS.SI-ID:20662502 This link opens in a new window
Publication date in RUL:11.07.2014
Views:1934
Downloads:208
Metadata:XML DC-XML DC-RDF
:
ŠTEFANČIČ, Miha, 2011, Primerjava naložbenega zavarovanja Junior s konkurenčnimi zavarovanji v Sloveniji : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : M. Štefančič. [Accessed 17 April 2025]. Retrieved from: http://www.cek.ef.uni-lj.si/u_diplome/stefancic4623.pdf
Copy citation
Share:Bookmark and Share

Secondary language

Language:Unknown
Keywords:Slovenia, insurance, life insurance, investments, investment funds, competition, comparisons

Similar documents

Similar works from RUL:
  1. Systematic review of observational studies evaluating the effectiveness and safety of immune checkpoint inhibitors in patients with metastatic non-small-cell lung cancer
  2. Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
  3. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  4. ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
  5. Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
Similar works from other Slovenian collections:
  1. Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
  2. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  3. ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
  4. Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
  5. Neurological adverse events of immune checkpoint inhibitors

Back